Cargando…

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use

BACKGROUND: While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-related barriers. The objective of this study was to estimate the prevalence of patient-reported problems filling BUP prescriptions and determine whether these problems were a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winstanley, Erin L., Thacker, Emily P., Choo, Lyn Yuen, Lander, Laura R., Berry, James H., Tofighi, Babak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949336/ https://www.ncbi.nlm.nih.gov/pubmed/36844166 http://dx.doi.org/10.1016/j.dadr.2022.100091

Ejemplares similares

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Associations between prescription stimulant use as prescribed, nonmedical use, and illicit stimulant use among adults evaluated for substance use treatment, 2017-2021
por: Pickens, Cassandra M., et al.
Publicado: (2023)

Emergency-department initiated buprenorphine: Impact on quality of life
por: Carroll, Caleb, et al.
Publicado: (2023)

The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
por: Silwal, Anita, et al.
Publicado: (2023)

Inverse association of anti-inflammatory prescription fills and suicide-related mortality in young adults: Evidence from a nationwide study of Swedish regions, 2006–2021
por: Andersson, Peter, et al.
Publicado: (2023)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Enhancement of Expression Level of Modified t-PA (TNKase) in Leishmania tarentolae by Induction System
por: Yazdi, Mohammad Mehdi Attarpour, et al.
Publicado: (2019)

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
por: Wang, Xi, et al.
Publicado: (2023)

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
por: Ward, Kathleen M., et al.
Publicado: (2022)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
por: del Pozo, Brandon, et al.
Publicado: (2023)

Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice
por: Hamood, Yesmine, et al.
Publicado: (2022)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023)

Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016–June 2017
por: Mattson, Christine L., et al.
Publicado: (2018)

Motivational and psychological correlates of bodybuilding dependence
por: EMINI, NEIM N., et al.
Publicado: (2014)

Factor structure of the Cybersex Motives Questionnaire
por: Franc, Elisabeth, et al.
Publicado: (2018)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

The association between dual use of electronic nicotine products and illicit drugs with adverse cardiovascular and respiratory outcomes in a longitudinal analysis using the Population Assessment of Tobacco and Health (PATH) survey
por: Qeadan, Fares, et al.
Publicado: (2023)

Psychometric evaluation of the treatment entry questionnaire to assess extrinsic motivation for inpatient addiction treatment
por: Walji, Alyna, et al.
Publicado: (2021)

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial
por: Janzow, Grace E., et al.
Publicado: (2022)

Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
por: Anderson Goodell, Erin M., et al.
Publicado: (2021)

Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden
por: Richert, Torkel, et al.
Publicado: (2013)

Motives to use Facebook and problematic Facebook use in adolescents
por: Marino, Claudia, et al.
Publicado: (2018)

Contribution of sexual desire and motives to the compulsive use of cybersex
por: Brahim, Farah Ben, et al.
Publicado: (2019)

The gambler’s fallacy in problem and non-problem gamblers
por: Matarazzo, Olimpia, et al.
Publicado: (2019)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

Foundations of attention sharing: Orienting and responding to attention in term and preterm 5-month-old infants
por: Gattis, Merideth, et al.
Publicado: (2020)

The personality, motivational, and need-based background of problematic Tinder use
por: Orosz, Gábor, et al.
Publicado: (2018)

Exercise motivational regulations and exercise addiction: The mediating role of passion
por: Sicilia, Álvaro, et al.
Publicado: (2018)

Social anxiety and Internet gaming disorder: The role of motives and metacognitions
por: Marino, Claudia, et al.
Publicado: (2020)

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
por: Nguyen, Thuy, et al.
Publicado: (2022)

Prophylactic and Therapeutic Effects of Oleuropein on Reperfusion-Induced Arrhythmia in Anesthetized Rat
por: Baharvand, Babak, et al.
Publicado: (2016)

Consistency of maternal cognitions and principles across the first five months following preterm and term deliveries
por: Winstanley, A., et al.
Publicado: (2014)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
por: Dash, Genevieve F., et al.
Publicado: (2022)

CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts
por: Rodriguez del Rio, Pablo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cek6bhkinujj8d9dcq045mofsv